Status:
RECRUITING
Biological Markers for Post-Traumatic Stress Disorder
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Post Traumatic Stress Disorder
Eligibility:
MALE
20-60 years
Brief Summary
The current study aims to evaluate the sensitivity and specificity of a combination of various objective biomarkers for the diagnosis of PTSD.
Detailed Description
PTSD affects a major fraction of military combatants and is also very common in the general population. Like other psychiatric conditions, the diagnosis of PTSD is currently based on an interview and ...
Eligibility Criteria
Inclusion
- The willingness and ability to read, understand and sign an informed consent form.
- Age 20-60 years.
- A history of more than 2 years of combat service, and of at least one potentially life-threatening combat experience.
- One year or more after the last combat experience.
Exclusion
- Inability to attend scheduled clinic visits or comply with the study protocol
- A history of traumatic brain injury or any other known brain pathology.
- Substance use, except for prescribed cannabis, if it can be withheld for at least 24 hours prior to the study evaluation.
- A current psychiatric disorder other than PTSD.
- The inability to perform an awake brain MRI.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05213858
Start Date
January 1 2022
End Date
January 1 2026
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf-Harofeh Medical Center
Ramla, Israel, 70300